Valuation: BioElectronics Corporation

Market Cap 12.35M 11.06M 10.18M 9.22M 17.24M 1.17B 17.56M 121M 48.71M 617M 46.36M 45.37M 1.95B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 23.01M 21.17M 19.18M 35.85M 2.44B 36.52M 252M 101M 1.28B 96.43M 94.38M 4.05B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+33.33%
Current month+33.33%
1 month+100.00%
3 months+33.33%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+33.33%-.--%+33.33% 7.41M
-0.74%+3.27%+25.11%+60.30% 262B
-2.00%+0.88%+8.13%+25.62% 167B
-3.25%-4.45%-18.46%+67.19% 156B
-1.43%-8.33%-58.35%-16.31% 61.87B
-2.53%+3.65%+10.59%+48.04% 54.44B
0.00%+2.46%-11.97%-6.29% 53.3B
-3.47%+1.41%+22.42%+73.48% 51.07B
+0.70%-3.29%+9.61%+64.19% 50.25B
-3.63%+1.79%+34.67%+95.09% 47.17B
Average -1.54%+1.52%+2.17%+44.46% 90.26B
Weighted average by Cap. -1.63%+2.44%+5.16%+47.94%

Financials

2020 2021
Net sales 830K 743K 683K 619K 1.16M 78.77M 1.18M 8.15M 3.27M 41.43M 3.11M 3.05M 131M 1.61M 1.44M 1.33M 1.2M 2.25M 153M 2.29M 15.81M 6.35M 80.39M 6.04M 5.91M 254M
Net income -1.16M -1.04M -955K -866K -1.62M -110M -1.65M -11.39M -4.57M -57.92M -4.35M -4.26M -183M -290K -260K -239K -216K -404K -27.52M -412K -2.85M -1.14M -14.48M -1.09M -1.06M -45.65M
Net Debt 13.07M 11.7M 10.77M 9.75M 18.23M 1.24B 18.57M 128M 51.54M 653M 49.04M 48M 2.06B 13.34M 11.95M 10.99M 9.96M 18.62M 1.27B 18.96M 131M 52.62M 666M 50.07M 49.01M 2.1B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
29/10/26 $0.000300 -.--% 120,000
28/10/26 $0.000300 -.--% 9,174,694
27/10/26 $0.000300 -.--% 343,500
26/10/26 $0.000300 -.--% 379,500
23/10/26 $0.000300 -.--% 5,059,897
  1. Stock Market
  2. Stocks
  3. BIEL Stock